Innate Pharma

The next generation of immunotherapy? Innate Pharma targets NK cells

https://pharmaphorum.com/views-and-analysis/the-next-generation-of-immunotherapy-innate-pharma/

Innate Pharma gains rights to AZ’s recently approved leukaemia drug

https://pharmaphorum.com/news/innate-pharma-gains-rights-to-azs-recently-approved-leukaemia-drug/

Future uncertain for Innate and BMS’ troubled lirilumab

https://pharmaphorum.com/news/future-uncertain-innate-bms-troubled-lirilumab/

Innate and BMS’ immunotherapy fails in phase 2 trial

https://pharmaphorum.com/news/innates-immunotherapy-fails-phase-2-aml-trial/

Some good news for BMS with Opdivo + natural killer cell combination

https://pharmaphorum.com/news/bms-combine-opdivo-next-gen-immunotherapy/

Close in 10 seconds

Pharmaphorum.com

Search